Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia

Update Il y a 4 ans
Reference: NCT02461316

Woman and Man

  • | Country :
  • Serbia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Evaluation of safety profile and tolerability of MabThera (rituximab) in combination with chemotherapy (fludarabine and cyclophosphamide) in the treatment of Chronic Lymphocytic Leukemia (CLL).


Inclusion criteria

  • Lymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, Cancer

Links